{"id":"crystalline-lactulose","safety":{"commonSideEffects":[{"rate":null,"effect":"Abdominal bloating"},{"rate":null,"effect":"Flatulence"},{"rate":null,"effect":"Abdominal cramping"},{"rate":null,"effect":"Diarrhea"}]},"_chembl":null,"_dailymed":{"setId":"59e75426-42ae-4904-941f-009181101a8a","title":"LACTULOSE CRYSTALLINE (LACTULOSE) POWDER, FOR SOLUTION [CUMBERLAND ASSURED PRODUCTS INC.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Lactulose passes through the small intestine largely unabsorbed and reaches the colon, where colonic bacteria ferment it into short-chain fatty acids and gases. This increases osmotic pressure in the colon, drawing water into the intestinal lumen and promoting bowel movements. Additionally, the fermentation products lower colonic pH, which may reduce ammonia absorption and support hepatic encephalopathy management.","oneSentence":"Lactulose is a non-absorbable disaccharide that acts as an osmotic laxative to increase stool frequency and soften stool consistency.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:09:10.560Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Constipation"},{"name":"Hepatic encephalopathy"}]},"trialDetails":[{"nctId":"NCT03666546","phase":"PHASE4","title":"Blood Glucose Response After Oral Intake of Lactulose in Mildly Constipated Patients With Diabetes Mellitus Type 2","status":"COMPLETED","sponsor":"Fresenius Kabi","startDate":"2018-11-26","conditions":"Diabetes Mellitus, Type 2","enrollment":24},{"nctId":"NCT02968498","phase":"NA","title":"Blood Glucose Response After Oral Intake of Lactulose in Healthy Volunteers","status":"COMPLETED","sponsor":"Fresenius Kabi","startDate":"2016-11","conditions":"Blood Glucose","enrollment":24},{"nctId":"NCT02123017","phase":"PHASE2","title":"Efficacy and Safety of Bisacodyl and Lactulose as a Preparation for Colonoscopy","status":"COMPLETED","sponsor":"Cumberland Pharmaceuticals","startDate":"2014-04","conditions":"Colonoscopy Preparation","enrollment":32},{"nctId":"NCT01650870","phase":"PHASE2","title":"Safety, Efficacy, and Patient Preference of Split-Dose Crystalline Lactulose as a Preparation for Colonoscopy in Adults","status":"COMPLETED","sponsor":"Benaroya Research Institute","startDate":"2012-07","conditions":"Colonoscopy","enrollment":40},{"nctId":"NCT00712543","phase":"PHASE4","title":"A Preference Study Comparing Kristalose® and Liquid Lactulose","status":"COMPLETED","sponsor":"Cumberland Pharmaceuticals","startDate":"2009-06","conditions":"Constipation","enrollment":50}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":10,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Crystalline Lactulose","genericName":"Crystalline Lactulose","companyName":"Benaroya Research Institute","companyId":"benaroya-research-institute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Lactulose is a non-absorbable disaccharide that acts as an osmotic laxative to increase stool frequency and soften stool consistency. Used for Constipation, Hepatic encephalopathy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}